{"id":"https://genegraph.clinicalgenome.org/r/3a3c6eee-057f-4d83-a35c-81e8884fdea1v1.0","type":"EvidenceStrengthAssertion","dc:description":"The association between the NDP gene and Norrie disease (ND) is well-characterized, with over 100 unique variants described in HGMD, including nonsense, missense, splice, and deletion variants reported in dozens of publications. Familial segregation data is readily available; only a subset are included in this curation. Experimental evidence includes several mouse models of disease and protein interaction studies highlighting NDP's role in FZD4 interaction and Wnt signaling. \n\nNOTE: In terms of X-linked intellectual disability, ND is incompletely penetrant. The main phenotype associated with ND is abnormal vascular development within the eye, and only ~50% of patients with ND exhibit intellectual disability.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3a3c6eee-057f-4d83-a35c-81e8884fdea1","GCISnapshot":"https://genegraph.clinicalgenome.org/r/335ce5aa-7f87-4b91-a447-928399f40f11","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/335ce5aa-7f87-4b91-a447-928399f40f11_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2018-03-21T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/335ce5aa-7f87-4b91-a447-928399f40f11_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2021-03-15T13:54:14.336Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/335ce5aa-7f87-4b91-a447-928399f40f11_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/335ce5aa-7f87-4b91-a447-928399f40f11_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d09e36e1-a02d-4ada-8633-5c8591533e2c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/565366b6-271c-438e-bc13-131ba0d66725","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1307245","rdfs:label":"Berger 1992, Pt 2843","phenotypes":["obo:HP_0000365","obo:HP_0001256"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d09e36e1-a02d-4ada-8633-5c8591533e2c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1307245","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a862ade-6808-4bd1-a8b4-cded20aa8ace","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.11:g.43958476G>C (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413008947"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3821e963-4342-4f9c-8de3-be8267c75664_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant already scored for unrelated Pt 7206 in same article.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fde12d58-11fb-4fdb-962a-ad83fe88394e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7627181","rdfs:label":"Schuback 1995, Pt 10017","ageType":"AgeAtReport","ageUnit":"Years","ageValue":33,"detectionMethod":"SSCP gel analysis with subsequent Sanger sequencing","firstTestingMethod":"PCR","phenotypes":"obo:HP_0012715","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3821e963-4342-4f9c-8de3-be8267c75664_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7627181","allele":{"id":"https://genegraph.clinicalgenome.org/r/2047496c-ec65-4d70-baec-4a2f05693abd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000266.4(NDP):c.325C>T (p.Arg109Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/285135"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/aabe3e18-7c49-4c13-ab79-ad757e0e12aa_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4618c20-8bd3-4b56-9698-a0151cef50a2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28922694","rdfs:label":"Andarva 2018 Family Proband","detectionMethod":"Sequencing performed in both forward and reverse directions for all three exons","firstTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/aabe3e18-7c49-4c13-ab79-ad757e0e12aa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28922694","allele":{"id":"https://genegraph.clinicalgenome.org/r/c6264b27-a37a-49fc-9ffe-9a204493676c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.11:g.43949960_43949961insCC (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658683089"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/940b6e38-d947-4ecd-b5c7-b65cdb8a5de3_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3b51863-ac61-46e9-812e-8d688cd89b51","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1303264","rdfs:label":"Meindl 1992, Pt 204","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"firstTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/940b6e38-d947-4ecd-b5c7-b65cdb8a5de3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1303264","allele":{"id":"https://genegraph.clinicalgenome.org/r/67f86bc3-bfa1-4705-a093-2e283b0f2372","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.11:g.43958560G>C (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413009142"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1a9bb1d3-2745-4ea3-93ff-37a5b1cd60d2_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22ff8021-c9b5-45a0-9fc4-f8d1a7695f88","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7627181","rdfs:label":"Schuback 1995, 7206","ageType":"AgeAtReport","ageUnit":"Years","ageValue":33,"detectionMethod":"PCR products examined by SSCP gel analysis followed by Sanger sequencing","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002187","obo:HP_0001249"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1a9bb1d3-2745-4ea3-93ff-37a5b1cd60d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7627181","allele":{"id":"https://genegraph.clinicalgenome.org/r/2047496c-ec65-4d70-baec-4a2f05693abd"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9b4006ea-d1e0-4c27-b56f-5ade3d8ba6a8_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16b7a52f-7ec9-4968-ae2c-02f3aa6a3379","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22786811","rdfs:label":"Smith 2012, Fam 22, Pt ND28","ageType":"AgeAtReport","ageUnit":"Years","ageValue":21,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9b4006ea-d1e0-4c27-b56f-5ade3d8ba6a8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22786811","allele":{"id":"https://genegraph.clinicalgenome.org/r/32002c1e-759b-4038-925e-12b489ffc915","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.11:g.43949906G>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413007505"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/dfb2139c-bd98-4288-a9ea-6b29c613c1e4_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f106767-9f6e-4ca1-bf32-9e5a581b26bf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8990009","rdfs:label":"A.G.","ageType":"AgeAtReport","ageUnit":"Months","ageValue":6,"detectionMethod":"SSCP with subsequent Sanger sequencing","firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/dfb2139c-bd98-4288-a9ea-6b29c613c1e4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8990009","allele":{"id":"https://genegraph.clinicalgenome.org/r/948c37d7-bdc2-4554-aaf3-a6700faeb273","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000266.4(NDP):c.218C>A (p.Ser73Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/10698"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d0e9a1c9-ddca-412d-b694-c98246dc9533_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant already scored. Identified in two additional affected males of a different kindred (Fam22: ND28 and ND29) described in article.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c3c7f69-7df9-45d2-965f-d8d38f1de4aa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22786811","rdfs:label":"Smith 2012, Fam 23, Pt ND30","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d0e9a1c9-ddca-412d-b694-c98246dc9533_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22786811","allele":{"id":"https://genegraph.clinicalgenome.org/r/32002c1e-759b-4038-925e-12b489ffc915"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6ad0eae6-e74c-4fdd-a51d-3b83feabd523_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant also detected in Pt G. of different kindred, reported in same article.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/220820fa-a7ad-4a5e-aeb9-efd638e24e74","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1307245","rdfs:label":"Berger 1992, Pt A.La.","firstTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6ad0eae6-e74c-4fdd-a51d-3b83feabd523_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1307245","allele":{"id":"https://genegraph.clinicalgenome.org/r/71cf3027-e2b5-4baa-9795-0a1f0c703471","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.11:g.43949871G>T (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413007397"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":10},{"id":"https://genegraph.clinicalgenome.org/r/335ce5aa-7f87-4b91-a447-928399f40f11_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4227848-7e9b-4a7e-b8f0-5fcdbd9195fd_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53d3de67-da64-4b82-a996-d724ed1703dc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9109762","rdfs:label":"Sims 1997, female with ND","detectionMethod":"Targeted sequencing for known familial variant previously identified in two uncles with Norrie disease","firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d4227848-7e9b-4a7e-b8f0-5fcdbd9195fd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9109762","allele":{"id":"https://genegraph.clinicalgenome.org/r/07d068f1-9a0b-449d-b5f9-3b4e7c72f094","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.11:g.43949833A>T (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413007306"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9d0f9b38-4192-4915-a957-5dc8ea4354cf_proband_score_evidence_line","type":"EvidenceLine","dc:description":"As reported by Xu et al 2004, this variant is associated with protein mislocalization and decreased cell signaling function compared to WT.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c4e447f-4d06-4cd5-991b-d74585f5972f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9143918","rdfs:label":"Rehm 1997 Family, IV-1","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"All affected males showed congenital bilateral blindness.","phenotypes":["obo:HP_0000408","obo:HP_0007875"],"secondTestingMethod":"Genotyping","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9d0f9b38-4192-4915-a957-5dc8ea4354cf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9143918","allele":{"id":"https://genegraph.clinicalgenome.org/r/ccb4b9e4-33a4-47f6-9430-b542c9e786d2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000266.4(NDP):c.181C>T (p.Leu61Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/10690"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/335ce5aa-7f87-4b91-a447-928399f40f11_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a9c1dd7-57e2-47fc-b7fd-dc38c34bf5f7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9143918","rdfs:label":"Rehm 1997 Family","family":{"id":"https://genegraph.clinicalgenome.org/r/7a9c1dd7-57e2-47fc-b7fd-dc38c34bf5f7","type":"Family","rdfs:label":"Rehm 1997 Family","member":{"id":"https://genegraph.clinicalgenome.org/r/4c4e447f-4d06-4cd5-991b-d74585f5972f"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"All affected males showed congenital bilateral blindness.","phenotypePositiveAllelePositive":10,"phenotypes":["obo:HP_0000408","obo:HP_0007875"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/4c4e447f-4d06-4cd5-991b-d74585f5972f"},"publishedLodScore":2.723,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/21bf22e2-b078-4d0c-997c-bda686ee2da2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8990009","rdfs:label":"Walker 1997, Family Q","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/21bf22e2-b078-4d0c-997c-bda686ee2da2","type":"Family","rdfs:label":"Walker 1997, Family Q","member":{"id":"https://genegraph.clinicalgenome.org/r/5f106767-9f6e-4ca1-bf32-9e5a581b26bf"}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/5f106767-9f6e-4ca1-bf32-9e5a581b26bf"}},{"id":"https://genegraph.clinicalgenome.org/r/e9e61e64-f3b5-48e9-89ab-6ee5a852a775_proband_segregation","type":"FamilyCosegregation","dc:description":"All family members tested. 4 affected males tested positive for NDP variant, as well as 4 female carriers","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28922694","rdfs:label":"Andarva 2018 Family","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/e9e61e64-f3b5-48e9-89ab-6ee5a852a775","type":"Family","rdfs:label":"Andarva 2018 Family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/f4618c20-8bd3-4b56-9698-a0151cef50a2"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":8,"proband":{"id":"https://genegraph.clinicalgenome.org/r/f4618c20-8bd3-4b56-9698-a0151cef50a2"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/335ce5aa-7f87-4b91-a447-928399f40f11_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/335ce5aa-7f87-4b91-a447-928399f40f11_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9624e3b3-cdd7-409d-ab22-d25d1bb7f254","type":"EvidenceLine","dc:description":"Additional phenotype correlation b/w human and mouse ND, using same mouse model as in Berger et al 1996.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/960332f7-c066-4acb-8047-01dce8631883","type":"Finding","dc:description":"\"We have demonstrated progressive hearing loss leading to profound deafness in Ndp knock-out mice. The loss is similar to that in human patients with Norrie disease; it is progressive, affects all frequencies, and is more severe in the high frequencies. Although there is some variability in the severity and age of onset, the penetrance appears to be complete. Early descriptions of the human Norrie disease clinical phenotype document a much lower incidence, with only one-third of patients expressing hearing loss.\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12040033","rdfs:label":"Rehm 2002","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ac466e31-2253-43d5-9cb0-d7c8e5dca769","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1a1f8c2-5084-49df-9211-716ed1d85ed5","type":"Finding","dc:description":"\"Retrolental masses, falciform fold of the retina and retinal detachment are the most common and prominent ocular findings in ND patients...Upon slit-lamp biomicroscopy of hemi-zygous mutant mice, changes within the vitreous body were observed that were strikingly similar to early ocular manifestations of ND in humans...The most prominent findings in histological sections were fibrous masses within the vitreous bodies of all eyes examined.\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8789439","rdfs:label":"Berger 1996 KO mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/afaed431-67bd-4aed-8faa-34fee1bb0733","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49b2af5d-687d-498b-bd77-8cdc24ace98f","type":"Finding","dc:description":"\"The phenotype of Nor-29/Ndpy/- mice was analyzed at P21, when the development of the retinal vasculature has been completed in the mouse eye and vessels have grown out from the primary vasculature within the nerve fiber layer to form a capillary bed in the outer plexiform layer and a second one in the inner plexiform layer (Connolly et al., 1988; Provis, 2001; Fruttiger, 2002). In Nor-29/Ndpy/- animals, both retinal capillary beds were present and could be visualized by conventional light microscopy (Fig. 4A,C), electron microscopy (Fig. 4E), and labeling of vascular endothelial cells with biotinylated G. (bandeira) simplicifolia lectin I (Fig. 4G). The capillaries showed the typical ultrastructural characteristics of retinal capillaries and were covered by pericytes and surrounded by a complete basal lamina (Fig. 4E). In contrast to Nor-29/Ndpy/- animals, Ndpy/- littermates expressed vascular membranes at the inner surface of the retina (Fig. 4B), whereas capillaries within the retinal layers were not observed (Fig. 4H).\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15716406","rdfs:label":"Ohlmann 2005, Lens-specific NDP expression transgenic mouse","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/335ce5aa-7f87-4b91-a447-928399f40f11_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/515b5473-d886-43ac-a5b3-294528f462c0","type":"EvidenceLine","dc:description":"Multiple disease-associated variants demonstrate decreased cell signaling.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bbfbd721-4580-4eb3-b593-1f87696ea8ae","type":"FunctionalAlteration","dc:description":"\"Figure 8A shows that, with the exception of L13R, which resides in the signal peptide, all of the mutant proteins accumulate in the ECM to levels roughly comparable to or greater than the wt control. In the STF signaling assay, 11 of 18 mutants show less than half the wt activity level (Figure 8B).\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15035989","rdfs:label":"Wu 2004, Figure 8"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/335ce5aa-7f87-4b91-a447-928399f40f11_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f14c495-48f9-4cfb-960e-7ad111cd53b5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0050893-161c-42c1-9154-201d0c5377c1","type":"Finding","dc:description":"Primer specific to the first exon and 3' UTR of the NDP gene were used to PCR amplify cDNA synthesized from various tissues. The expected NDP framents were detected in all samples of fetal eye and fetal and adult brain.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8314592","rdfs:label":"Chen 1993, NDP expression in human tissue","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":2391,"specifiedBy":"GeneValidityCriteria5","strengthScore":17.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/QmIKCDRO0h4","type":"GeneValidityProposition","disease":"obo:MONDO_0010691","gene":"hgnc:7678","modeOfInheritance":"obo:HP_0001417"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_335ce5aa-7f87-4b91-a447-928399f40f11-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}